C H M Jamieson

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions
    Omer Raheem
    Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
    J Transl Med 9:185. 2011
  2. pmc Chronic myeloid leukemia stem cell biology
    Leslie A Crews
    Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093 0820, USA
    Curr Hematol Malig Rep 7:125-32. 2012
  3. doi request reprint Miscreant myeloproliferative disorder stem cells
    C H M Jamieson
    Department of Medicine, Moores UCSD Cancer Center San Diego Medical Center, University of California, La Jolla, CA 92093 0820, USA
    Leukemia 22:2011-9. 2008
  4. doi request reprint The MLLgnant consequences of reverting to an embryonic transcriptional program
    Catriona Jamieson
    Stem Cell Research Program, Division of Hematology Oncology, Moores UCSD Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA
    Cell Stem Cell 4:97-8. 2009

Collaborators

  • Leslie A Crews
  • Omer Raheem
  • Heather Leu
  • Daniel Goff
  • Kristen M Smith
  • Christopher J Kane
  • Christina Wu
  • Nicholas A Cacalano
  • Tomonori Yamaguchi
  • Sheldon R Morris
  • Anna A Kulidjian
  • Koichi Masuda
  • Young B Jeong

Detail Information

Publications4

  1. pmc A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions
    Omer Raheem
    Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
    J Transl Med 9:185. 2011
    ....
  2. pmc Chronic myeloid leukemia stem cell biology
    Leslie A Crews
    Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093 0820, USA
    Curr Hematol Malig Rep 7:125-32. 2012
    ....
  3. doi request reprint Miscreant myeloproliferative disorder stem cells
    C H M Jamieson
    Department of Medicine, Moores UCSD Cancer Center San Diego Medical Center, University of California, La Jolla, CA 92093 0820, USA
    Leukemia 22:2011-9. 2008
    ..Thus, combined therapies targeting aberrant molecular pathways may be required to redirect miscreant MPD stem cells...
  4. doi request reprint The MLLgnant consequences of reverting to an embryonic transcriptional program
    Catriona Jamieson
    Stem Cell Research Program, Division of Hematology Oncology, Moores UCSD Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA
    Cell Stem Cell 4:97-8. 2009
    ..2009) have demonstrated convincingly that reversion to an embryonic transcriptional program through defective MLL gene expression contributes to the generation of myeloid leukemia stem cells...